$VGAS
Verde Clean Fuels Inc Stock $vgas

$vgas Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024042980 Filed on May 14, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.789M	$4.230M
YoY Change	-34.06%	1411.31%
% of Gross Profit
Research & Development	$85.84K	$82.66K
YoY Change	3.84%	-14.99%
% of Gross Profit
Depreciation & Amortization	$3.037K	$580.00
YoY Change	423.62%	-78.63%
% of Gross Profit
Operating Expenses	$85.84K	$82.66K
YoY Change	3.84%	-70.47%
Operating Profit	-$2.875M	-$3.117M
YoY Change	-7.76%	118.7%
Interest Expense		-$70.00K
YoY Change		-522.71%
% of Operating Profit
Other Income/Expense, Net	$346.1K
YoY Change
Pretax Income	-$2.529M	-$3.120M
YoY Change	-18.94%	1084.87%
Income Tax
% Of Pretax Income
Net Earnings	-$772.4K	-$3.117M
YoY Change	-75.22%	233.24%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.13	-$0.09
Diluted Earnings Per Share	-$0.13	-$0.09
COMMON SHARES
Basic Shares Outstanding	6.174M shares	6.124M shares
Diluted Shares Outstanding	6.174M shares	6.124M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.94M	$34.81M
YoY Change	-25.48%	22224.12%
Cash & Equivalents	$25.94M	$34.81M
Short-Term Investments
Other Short-Term Assets	$1.506M	$1.700M
YoY Change	-11.41%	900.0%
Inventory
Prepaid Expenses	$1.406M	$1.571M
Receivables
Other Receivables
Total Short-Term Assets	$27.45M	$36.51M
YoY Change	-24.82%	11101.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.79K	$6.834K
YoY Change	891.97%
Goodwill
YoY Change
Intangibles	$1.925M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.7K	$1.925M
YoY Change	-91.65%
Total Long-Term Assets	$2.607M	$7.891M
YoY Change	-66.96%	-95.47%
TOTAL ASSETS
Total Short-Term Assets	$27.45M	$36.51M
Total Long-Term Assets	$2.607M	$7.891M
Total Assets	$30.06M	$44.40M
YoY Change	-32.31%	-74.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$367.0K	$242.8K
YoY Change	51.17%	-69.3%
Accrued Expenses	$2.228M	$995.3K
YoY Change	123.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$420.0K
YoY Change	-100.0%
Long-Term Debt Due		$190.0K
YoY Change
Total Short-Term Liabilities	$2.953M	$2.338M
YoY Change	26.29%	1869.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$5.270M
YoY Change	-100.0%
Other Long-Term Liabilities	$147.5K	$1.670M
YoY Change	-91.17%	-72.34%
Total Long-Term Liabilities	$147.5K	$6.942M
YoY Change	-97.88%	14.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.953M	$2.338M
Total Long-Term Liabilities	$147.5K	$6.942M
Total Liabilities	$3.101M	$9.280M
YoY Change	-66.59%	50.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.70M	-$21.75M
YoY Change	13.52%
Common Stock		$936.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.98M	$12.17M
YoY Change
Total Liabilities & Shareholders Equity	$30.06M	$44.40M
YoY Change	-32.31%	-74.57%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$772.4K	-$3.117M
YoY Change	-75.22%	233.24%
Depreciation, Depletion And Amortization	$3.037K	$580.00
YoY Change	423.62%	-78.63%
Cash From Operating Activities	-$2.829M	-$2.846M
YoY Change	-0.59%	714.11%
INVESTING ACTIVITIES
Capital Expenditures	$8.323K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$8.323K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$37.20M
YoY Change
NET CHANGE
Cash From Operating Activities	-$2.829M	-$2.846M
Cash From Investing Activities	-$8.323K
Cash From Financing Activities		$37.20M
Net Change In Cash	-$2.838M	$34.35M
YoY Change	-108.26%
FREE CASH FLOW
Cash From Operating Activities	-$2.829M	-$2.846M
Capital Expenditures	$8.323K	$0.00
Free Cash Flow	-$2.838M	-$2.846M
YoY Change	-0.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40743
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Verde Clean Fuels, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1863331
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	711 Louisiana St
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2160
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
CY2024Q1	dei	City Area Code CityAreaCode	(908)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	281-6000
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25941604	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28779177	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1406010	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	373324	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	27447614	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	29252501	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160669	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	160669	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67791	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62505	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	453862	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	524813	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2607473	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2673138	usd
CY2024Q1	us-gaap	Assets Assets	30055087	usd
CY2023Q4	us-gaap	Assets Assets	31925639	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	367036	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	184343	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2227546	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	326446	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	297380	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	32027	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2953055	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2458535	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	147472	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	232162	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	147472	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	641774	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3100527	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3100309	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35673145	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35014836	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24695101	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23922730	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	15973323	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	17730035	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26954560	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30055087	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31925639	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2789376	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4265640	usd
CY2023Q1	cenqu	Contingent Consideration Amount ContingentConsiderationAmount	-1299000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	85835	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	82662	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2875211	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3049302	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	346128	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	67825	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2529083	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3117127	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2529083	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3117127	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1756712	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2542666	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-772371	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-574461	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28825330	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	409612	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	248701	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2529083	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26954560	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1103365	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1103365	usd
CY2023Q1	cenqu	Reversal Of Intermediate Original Equity ReversalOfIntermediateOriginalEquity	-1103365	usd
CY2023Q1	cenqu	Stockissue During Period Value Recapitalization Transaction StockissueDuringPeriodValueRecapitalizationTransaction	36089053	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2146792	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3117127	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35118718	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2529083	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3117127	usd
CY2023Q1	cenqu	Contingent Consideration Non Cash Activities ContingentConsiderationNonCashActivities	1299000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	3037	usd
CY2023Q1	us-gaap	Depreciation Depreciation	580	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	248701	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2146792	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36463	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	70951	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	55085	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1032686	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1457643	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	182693	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51810	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	250734	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	792085	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-55624	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-55085	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-32027	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2829250	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2846040	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8323	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8323	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32000000	usd
CY2023Q1	cenqu	Proceeds From Trust ProceedsFromTrust	19031516	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10043793	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3750000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3719	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12508	usd
CY2023Q1	cenqu	Payment For Deferred Financing Costs PaymentForDeferredFinancingCosts	22570	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37198926	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2837573	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	34352886	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28879177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463475	usd
CY2023Q1	cenqu	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired	91454	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26041604	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34907815	usd
CY2023Q1	cenqu	Income Tax Payable IncomeTaxPayable	312446	usd
CY2023Q1	cenqu	Accrued Deferred Transaction Costs AccruedDeferredTransactionCosts	409279	usd
CY2024Q1	cenqu	Federal Statutory Excise Tax Rate Percent FederalStatutoryExciseTaxRatePercent	0.01	pure
CY2024Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	1000000	usd
CY2024Q1	cenqu	Excise Tax On Fair Market Value Share Repurchases ExciseTaxOnFairMarketValueShareRepurchases	0.01	pure
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	158900000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.01	pure
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	31858620	shares
CY2023Q1	cenqu	Percentage Of Common Stock PercentageOfCommonStock	1	pure
CY2023Q1	cenqu	Earn Out Equity Shares EarnOutEquityShares	3500000	shares
CY2023Q1	cenqu	Diluted Shares At Closing DilutedSharesAtClosing	35358620	shares
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The most significant estimates pertain to the calculations of the fair values of equity instruments, impairment of intangible and long-lived assets and income taxes. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	23882130	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	26155789	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation (“FDIC”) limit of $250,000. Additionally, the majority of the Company’s cash balances are held in a short-term money market fund that is not guaranteed by the FDIC. As of March 31, 2024 and December 31, 2023, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	cenqu	Accrued Legal Fees AccruedLegalFees	257080	usd
CY2023Q4	cenqu	Accrued Legal Fees AccruedLegalFees	237839	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	370003	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	143900	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1587975	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12488	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7098	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2227546	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1976812	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1925151	usd
CY2022Q3	cenqu	Percentage Of Units PercentageOfUnits	0.10	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2146792	usd
CY2023Q1	cenqu	Business Combination Contingent Consideration Arrangements Accrued Contingent Consideration Reversed BusinessCombinationContingentConsiderationArrangementsAccruedContingentConsiderationReversed	-1299000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.05	pure
CY2023Q1	cenqu	Deferred Underwriting Fees DeferredUnderwritingFees	1700000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31858620	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31858620	shares
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32000000	usd
CY2023Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	3750000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In October 2022, the Company entered into a 25-year land lease in Maricopa, Arizona with the intent of building a renewable gasoline processing facility. The commencement date of the lease was in February 2023 as control of the identified asset did not transfer to the Company on the effective date of the lease. On the commencement date, the present value of the minimum lease payments exceeded the fair value of the land, and, accordingly, the lease was classified as a finance lease.
CY2024Q1	us-gaap	Lease Cost LeaseCost	118666	usd
CY2023Q1	cenqu	Finance Lease Cost FinanceLeaseCost	104287	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	199612	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	453862000000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	268085000000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M23D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y29D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	5432847000000	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P24Y9M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15383263	shares
CY2024Q1	cenqu	Number Of Trading Days For Determining The Newly Issued Share Price NumberOfTradingDaysForDeterminingTheNewlyIssuedSharePrice	P20D
CY2024Q1	cenqu	Number Of Consecutive Trading Days For Determining The Newly Issued Share Price NumberOfConsecutiveTradingDaysForDeterminingTheNewlyIssuedSharePrice	P30D
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.85	pure
CY2024Q1	cenqu	Net Cash Saving Percentage NetCashSavingPercentage	0.15	pure
CY2024Q1	cenqu	Payment Cap Tax Sharing Agreement PaymentCapTaxSharingAgreement	50000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-772371	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-574461	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6173716	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6124245	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6173716	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6124245	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	40963000000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19995310	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18687817	shares
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2024Q1	cenqu	Contingent Consideration Amount ContingentConsiderationAmount		usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2024Q1	cenqu	Contingent Consideration Non Cash Activities ContingentConsiderationNonCashActivities		usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	cenqu	Proceeds From Trust ProceedsFromTrust		usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2024Q1	cenqu	Payment For Deferred Financing Costs PaymentForDeferredFinancingCosts		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q1	cenqu	Cenaq Operatings Cash Balance Acquired CENAQOperatingsCashBalanceAcquired		usd
CY2024Q1	cenqu	Income Tax Payable IncomeTaxPayable		usd
CY2024Q1	cenqu	Accrued Deferred Transaction Costs AccruedDeferredTransactionCosts		usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2024Q1	cenqu	Business Combination Contingent Consideration Arrangements Accrued Contingent Consideration Reversed BusinessCombinationContingentConsiderationArrangementsAccruedContingentConsiderationReversed		usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2024Q1	cenqu	Warrants Exercised WarrantsExercised		shares
CY2023Q1	cenqu	Warrants Exercised WarrantsExercised		shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001841425

Files In Submission

Name	View Source	Status
0001213900-24-042980-index-headers.html	Edgar Link	pending
0001213900-24-042980-index.html	Edgar Link	pending
0001213900-24-042980.txt	Edgar Link	pending
0001213900-24-042980-xbrl.zip	Edgar Link	pending
cenqu-20240331.xsd	Edgar Link	pending
ea0205269-10q_verde.htm	Edgar Link	pending
ea020526901ex31-1_verde.htm	Edgar Link	pending
ea020526901ex31-2_verde.htm	Edgar Link	pending
ea020526901ex32-1_verde.htm	Edgar Link	pending
ea020526901ex32-2_verde.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
cenqu-20240331_cal.xml	Edgar Link	unprocessable
cenqu-20240331_def.xml	Edgar Link	unprocessable
cenqu-20240331_lab.xml	Edgar Link	unprocessable
cenqu-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205269-10q_verde_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VGAS
Verde Clean Fuels Inc Stock $vgas

2024 Q1 Form 10-Q Financial Statement

#000121390024042980 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS Verde Clean Fuels Inc Stock $vgas

2024 Q1 Form 10-Q Financial Statement

#000121390024042980 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VGAS
Verde Clean Fuels Inc Stock $vgas